ReviewA Molecular Functional Study on the Interactions of Drugs with Plasma Proteins
References (111)
Binding of drugs by albumin and plasma protein
J. Pharm. Sci.
(1977)- et al.
Structure of serum albumin
Adv. Protein Chem.
(1994) - et al.
Characterization of site I on human serum albumin: concept about the structure of a drug binding site
Biochim. Biophys. Acta
(1996) - et al.
Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures
J. Biol. Chem.
(2000) - et al.
Inhaled anesthetic binding sites in human serum albumin
J. Biol. Chem.
(2000) - et al.
Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine
J. Biol. Chem.
(2001) - et al.
Cisplatin binding sites on human albumin
J. Biol. Chem.
(1998) - et al.
Kinetic analysis of the covalent binding of captopril to human serum albumin
J. Pharm. Sci.
(1997) - et al.
Determination of reduced, protein-unbound, and total concentrations of N-acetyl-L-cysteine and L-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography
Anal. Biochem.
(2001) - et al.
Nuclear magnetic resonance studies of the binding of captopril and penicillamine by serum albumin
Biochem. Pharmacol.
(1993)
Studies on the reactivity of acyl glucuronides—VII. Salicyl acyl glucuronide reactivity in vitro and covalent binding of salicylic acid to plasma protein of humans taking aspirin
Biochem. Pharmacol.
(1994)
Study of interaction of carprofen and its enantiomers with human serum albumin—II. Stereoselective site-to-site displacement of carprofen by ibuprofen
Biochem. Pharmacol.
(1993)
Structural basis of the drug-binding specificity of human serum albumin
J. Mol. Biol.
(2005)
Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney
Kidney Int.
(2002)
The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants
Biochim. Biophys. Acta
(2003)
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial
Liver Transpl.
(2000)
Use of MARS in the treatment of acute liver failure: preliminar monocentric experience
Transplant. Proc.
(2001)
Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins
J. Hepatol.
(1999)
Charcoal hemoperfusion in the treatment of phenytoin overdose
Am. J. Kidney Dis.
(2000)
Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues
Methods Enzymol.
(1999)
Plasma protein thiol oxidation and carbonyl formation in chronic renal failure
Kidney Int.
(2000)
Bovine mercaptalbumin and non-mercaptalbumin monomers. Interconversions and structural differences
J. Biol. Chem.
(1972)
Useful markers for detecting decreased serum antioxidant activity in hemodialysis patients
Am. J. Kidney Dis.
(2002)
Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients
Kidney Int.
(2004)
Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients
Free Radic. Biol. Med.
(2001)
Conformational study of alpha1-acid glycoprotein
Arch. Biochem. Biophys.
(1976)
Structure of human alpha1-acid glycoprotein and its high-affinity binding site
Biochem. Biophys. Res. Commun.
(2003)
Alpha1-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties
Cytokine Growth Factor Rev.
(2003)
Effects of tricyclic drug on induced circular dichroism spectra of dicumarol bound to alpha1-acid glycoprotein
Biochem. Pharmacol.
(1991)
Further characterization of reversal of signs of induced cotton effects of dicumarol derivatives-alpha1-acid glycoprotein systems by protriptyline
Biochem. Pharmacol.
(1992)
Use of photoaffinity labeling and site-directed mutagenesis for identification of the key residue responsible for extraordinarily high affinity binding of UCN-01 in human alpha1-acid glycoprotein
J. Biol. Chem.
(2005)
Characterization of benzodiazepine binding site on human alpha1-acid glycoprotein using flunitrazepam as a photolabeling agent
Biochim. Biophys. Acta.
(2005)
Characterization of ligand binding sites on the alpha1-acid glycoprotein in humans, bovines and dogs
Drug Metab. Pharmacokinet.
(2002)
Changes in expression and microheterogeneity of the genetic variants of human alpha1-acid glycoprotein in malignant mesothelioma
J. Chromatogr. B Biomed. Sci. Appl.
(1998)
The genetic variant A of human alpha1-acid glycoprotein limits the blood to brain transfer of drugs it binds
Life Sci.
(1998)
The binding of drugs by plasma proteins
J. Pharm. Sci.
(1967)
Plasma and tissue protein binding of drugs in pharmacokinetics
Drug. Metab. Rev.
(1976)
Specificity of binding sites on plasma protein: Drug protein binding
Drug binding to human alpha1-acid glycoprotein. Focus on a single binding site, Protein binding and drug transport
Pharmacokinetics in disease state changing protein binding: The effect of disease state on drug pharmacokinetics
Clinical implications of interindividual differences in plasma protein binding and endogenous substances: The effect of disease states on dug pharmacokinetics
Molecular aspects of ligand binding to serum albumin
Pharmacol. Rev.
(1981)
Drug binding to human alpha-1-acid glycoprotein in health and disease
Pharmacol. Rev.
(1988)
All about Albumin: Biochemistry, Genetics, and Medical Applications
(1996)
Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites
Nat. Struct. Biol.
(1998)
The characterization of two specific drug binding sites on human serum albumin
Mol. Pharmacol.
(1975)
Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants
Biochem. J.
(2001)
Atomic structure and chemistry of human serum albumin
Nature
(1992)
Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity
Biochem. J.
(2000)
Topology analysis of site II: A major drug binding region of human serum albumin
Cited by (201)
Evaluation of the effect of phenylpropanoids on the binding of heparin to human serum albumin and glycosylated human serum albumin concerning anticoagulant activity: A comparison study
2024, International Journal of Biological MacromoleculesProtein interactions and drug displacement studies of novel copper(II) and zinc(II) complexes of a dipyrazinylpyridine ligand
2023, Journal of Molecular LiquidsUnraveling the versatility of human serum albumin – A comprehensive review of its biological significance and therapeutic potential
2023, Current Research in Structural BiologyStudy the interactions between multiple flavonoids and bovine serum albumin by the developed equilibrium dialysis
2022, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
Copyright © 2005 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.